BlueCrest Capital Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,633
Closed -$453K 622
2019
Q3
$453K Buy
+3,633
New +$439K 0.03% 281
2018
Q4
Sell
-3,946
Closed -$361K 1471
2018
Q3
$361K Sell
3,946
-36,256
-90% -$3.22M 0.01% 931
2018
Q2
$3.42M Buy
+40,202
New +$3.39M 0.09% 220
2018
Q1
Sell
-3,233
Closed -$233K 1660
2017
Q4
$233K Buy
+3,233
New +$222K 0.01% 688
2017
Q2
Sell
-10,000
Closed -$534K 1137
2017
Q1
$534K Buy
+10,000
New +$540K 0.03% 421
2016
Q1
Sell
-16,812
Closed -$806K 1160
2015
Q4
$806K Buy
16,812
+11,140
+196% +$503K 0.03% 466
2015
Q3
$234K Buy
5,672
+772
+16% +$35.8K 0.01% 767
2015
Q2
$236K Sell
4,900
-100
-2% -$4.77K 0.01% 750
2015
Q1
$231K Buy
+5,000
New +$225K 0.01% 556

Other funds holding ZTS

BlueCrest Capital Management's ZTS Position: Q4 2019 in Review

BlueCrest Capital Management sold out of Zoetis (ZTS) in Q4 2019, closing a stake of 3,633 shares — an estimated $453K sold.

BlueCrest Capital Management first reported a position in ZTS in Q1 2015 and held it in 9 quarters. The position peaked at $3.42M in Q2 2018. 1,188 funds tracked by Wall St. Rank hold ZTS as of Q4 2019.

  • BlueCrest Capital Management reported no remaining Zoetis position as of Q4 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 3,633 Zoetis shares in Q4 2019, an estimated $453K.
  • BlueCrest Capital Management first reported a position in Zoetis in Q1 2015 and held it in 9 quarters.
  • BlueCrest Capital Management's Zoetis position peaked at $3.42M in Q2 2018.
  • 1,188 funds tracked by Wall St. Rank held Zoetis as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.